cab atezo: a new treatment for naïve advanced ccrcc
Published 3 years ago • 71 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:34
potential new biomarkers for advanced ccrcc treatment response identified
-
1:26
neoadjuvant cabozantinib in patients with locally advanced non-metastatic ccrcc
-
1:05
cohort 1 litespark-003: belzutifan cabozantinib 1l treatment for advanced rcc
-
2:53
immunotherapy and targeted therapy for advanced arcc
-
2:53
immunotherapy and targeted therapy for advanced arcc
-
0:35
the latest developments in adjuvant therapy for rcc
-
4:15
contact-303: primary pfs analysis of atezolizumab and cabozantinib in ccrcc
-
2:12
real-world study of atezolizumab vs. pembrolizumab for advanced/metastatic uc
-
5:16
potential new treatments in renal cell carcinoma
-
5:11
current treatment landscape for kidney cancer
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
2:36
imvigor010 & imvigor011: ctdna as a response biomarker for adjuvant atezolizumab in high-risk mibc
-
5:46
cabozantinib plus atezolizumab as first-line therapy for advanced renal cell carcinoma
-
1:06
key trials in kidney cancer at asco gu 2023
-
4:01
checkmate 9er trial: nivo cab vs sun 1l in advanced rcc
-
3:34
abacus trial: preoperative atezolizumab in urothelial carcinoma
-
7:24
atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis
-
3:06
solti-1503 prometeo: t-vec atezolizumab in patients with residual bc after neoadjuvant chemo
-
1:03
potential of adjuvant therapy for rcc